These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33892858)

  • 1. Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
    Drüeke TB; Floege J
    Kidney Int; 2021 May; 99(5):1070-1072. PubMed ID: 33892858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
    Ursem SR; Heijboer AC; D'Haese PC; Behets GJ; Cavalier E; Vervloet MG; Evenepoel P
    Kidney Int; 2021 May; 99(5):1173-1178. PubMed ID: 33422551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?
    Hocher B; Armbruster FP; Stoeva S; Reichetzeder C; Grön HJ; Lieker I; Khadzhynov D; Slowinski T; Roth HJ
    PLoS One; 2012; 7(7):e40242. PubMed ID: 22792251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
    Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocytic perilacunar/canalicular turnover in hemodialysis patients with high and low serum PTH levels.
    Yajima A; Tsuchiya K; Burr DB; Minner DE; Condon KW; Miller CA; Satoh S; Inaba M; Nakayama T; Tanizawa T; Ito A; Nitta K
    Bone; 2018 Aug; 113():68-76. PubMed ID: 29738853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.
    Hocher B; Oberthür D; Slowinski T; Querfeld U; Schaefer F; Doyon A; Tepel M; Roth HJ; Grön HJ; Reichetzeder C; Betzel C; Armbruster FP
    Kidney Blood Press Res; 2013; 37(4-5):240-51. PubMed ID: 23868100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of parathyroid hormone.
    Ursem SR; Vervloet MG; de Jongh RT; Heijboer AC
    Clin Chim Acta; 2020 Jul; 506():84-91. PubMed ID: 32178977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.
    Zeng S; Querfeld U; Feger M; Haffner D; Hasan AA; Chu C; Slowinski T; Bernd Dschietzig T; Schäfer F; Xiong Y; Zhang B; Rausch S; Horvathova K; Lang F; Karl Krämer B; Föller M; Hocher B
    FASEB J; 2020 Nov; 34(11):15269-15281. PubMed ID: 32964520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH assays in dialysis patients: Practical considerations.
    Soliman M; Hassan W; Yaseen M; Rao M; Sawaya BP; El-Husseini A
    Semin Dial; 2019 Jan; 32(1):9-14. PubMed ID: 30168196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid Hormone and Bone in Dialysis Patients.
    Kazama JJ; Wakasugi M
    Ther Apher Dial; 2018 Jun; 22(3):229-235. PubMed ID: 29883066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.
    Hruska KA; Korkor A; Martin K; Slatopolsky E
    J Clin Invest; 1981 Mar; 67(3):885-92. PubMed ID: 7204561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
    De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
    Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis.
    González-Casaus ML; González-Parra E; Sánchez-González C; Albalate M; de la Piedra-Gordo C; Fernández E; Torregrosa V; Rodríguez M; Lorenzo V
    Nefrologia; 2014 May; 34(3):330-40. PubMed ID: 24798561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
    Evenepoel P; Bover J; Ureña Torres P
    Kidney Int; 2016 Dec; 90(6):1184-1190. PubMed ID: 27653840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.
    Zheng CM; Wu CC; Lu CL; Hou YC; Wu MS; Hsu YH; Chen R; Chang TJ; Shyu JF; Lin YF; Lu KC
    Int J Med Sci; 2019; 16(12):1583-1592. PubMed ID: 31839746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach for evaluating bone turnover in chronic kidney disease.
    Tolouian R; Hernandez GT; Chiang WY; Gupta A
    Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.